Your browser doesn't support javascript.
loading
Graphene-based nanomaterials for cancer therapy and anti-infections.
Wang, Yan; Li, Juan; Li, Xiaobin; Shi, Jinping; Jiang, Zhaotan; Zhang, Can Yang.
Afiliação
  • Wang Y; School of Physics, Beijing Institute of Technology, Beijing, 100081, China.
  • Li J; Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, China.
  • Li X; Advanced Research Institute for Multidisciplinary Science, Beijing Institute of Technology, Beijing, 100081, China.
  • Shi J; Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, China.
  • Jiang Z; School of Physics, Beijing Institute of Technology, Beijing, 100081, China.
  • Zhang CY; School of Physics, Beijing Institute of Technology, Beijing, 100081, China.
Bioact Mater ; 14: 335-349, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35386816
Graphene-based nanomaterials (GBNMs) has been thoroughly investigated and extensively used in many biomedical fields, especially cancer therapy and bacteria-induced infectious diseases treatment, which have attracted more and more attentions due to the improved therapeutic efficacy and reduced reverse effect. GBNMs, as classic two-dimensional (2D) nanomaterials, have unique structure and excellent physicochemical properties, exhibiting tremendous potential in cancer therapy and bacteria-induced infectious diseases treatment. In this review, we first introduced the recent advances in development of GBNMs and GBNMs-based treatment strategies for cancer, including photothermal therapy (PTT), photodynamic therapy (PDT) and multiple combination therapies. Then, we surveyed the research progress of applications of GBNMs in anti-infection such as antimicrobial resistance, wound healing and removal of biofilm. The mechanism of GBNMs was also expounded. Finally, we concluded and discussed the advantages, challenges/limitations and perspective about the development of GBNMs and GBNMs-based therapies. Collectively, we think that GBNMs could be potential in clinic to promote the improvement of cancer therapy and infections treatment.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Bioact Mater Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Bioact Mater Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: China